4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 542.00
-20.50 (-3.64%)
Oct 15, 2026, 2:04 PM GMT
4basebio Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, 4basebio stock has a consensus rating of "Buy" and an average price target of 1,400p. The average 1-year stock price forecast is 158.30% higher than the current stock price, while the lowest is 1,000p (+84.50%) and the highest is 1,800p (+232.10%).
Price Target: 1,400p (+158.30%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for 4basebio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains 1,000p | Buy | Maintains | 1,000p | +84.50% | Sep 29, 2026 |
Financial Forecast
Revenue This Year
1.03M
from 1.69M
Decreased by -39.46%
Revenue Next Year
5.00M
from 1.03M
Increased by 387.80%
EPS This Year
-1.08
from -1.09
EPS Next Year
-0.85
from -1.08
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.